Dollar General's shares jumped over 10% following a robust earnings report, revealing a shift in customer demographics as more middle- and higher-income shoppers flock to the discount retailer amidst tariff fears.
In 'Mountainhead', Jesse Armstrong delivers a bleak yet hilarious comedy about billionaire friends whose poker weekend spirals into chaos as global violence unfolds. This sharp satire questions the morality of the ultra-rich.
King Charles III's visit to Canada underscores the nation's sovereignty amid U.S. annexation talks. With a speech from the throne, he reaffirms Canada's unique identity and constitutional monarchy.
King Charles III's upcoming visit to Canada aims to highlight the nation's sovereignty amidst U.S. President Trump's controversial comments about annexation. The king will deliver the speech from the throne, marking a pivotal moment in Canadian history.
The One Big Beautiful Bill Act proposed by Trump promises tax cuts but reveals a stark divide between high earners and low-income households. Discover the winners and losers in this controversial legislation!
The emerging GOP tax proposal could add over $2.5 trillion to the federal deficit, igniting fierce debate among lawmakers. Critics warn it risks an economic calamity by favoring tax cuts for the wealthy while slashing essential programs.
After intense internal debates, Republicans reveal their reconciliation bill, promising tax cuts for the wealthy while slashing vital social services. Will the working class pay the price for Trump's agenda?
In a party-line vote, the House Ways and Means Committee has passed a sweeping tax plan that includes significant cuts and new taxes targeting the wealthy, sparking fierce debate among lawmakers. Will it survive the Senate?
In a landmark move, President Trump signs an Executive Order aimed at reducing prescription drug prices for Americans, aligning them with those in other wealthy nations. This initiative seeks to curb unfair pricing practices and ensure a fair deal for U.S. patients.
President Trump is set to sign an executive order aiming to lower drug prices in the US by aligning them with prices in wealthy nations. This 'most favored nation' model could face legal challenges.
